Sign Up to like & get
recommendations!
1
Published in 2021 at "Endocrine"
DOI: 10.1007/s12020-021-02746-6
Abstract: Although low-density lipoprotein cholesterol (LDL-C) has been considered as a risk factor of atherosclerotic cardiovascular disease, limited studies can be available to evaluate the association of LDL-C with risk of mortality in the general population.…
read more here.
Keywords:
risk;
risk mortality;
ldl;
ldl levels ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "European heart journal"
DOI: 10.1093/eurheartj/ehaa1080
Abstract: Low-density lipoprotein cholesterol (LDL-C) is a proven causative factor for developing atherosclerotic cardiovascular disease. Individuals with genetic conditions associated with lifelong very low LDL-C levels can be healthy. We now possess the pharmacological armamentarium (statins,…
read more here.
Keywords:
safe frontier;
low safe;
ldl;
cholesterol ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Chinese Medical Journal"
DOI: 10.1097/cm9.0000000000002057
Abstract: Abstract The clinical efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) in reducing major cardiovascular adverse events related to atherosclerotic cardiovascular disease (ASCVD) has been well established in recent large randomized outcome trials. Although…
read more here.
Keywords:
low ldl;
bleeding risk;
therapy;
risk ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Stroke"
DOI: 10.1161/strokeaha.121.034924
Abstract: BACKGROUND Lp(a) (lipoprotein(a)) contributes to cardiovascular disease mainly through proatherogenic and proinflammatory effects. Here, we aimed to evaluate whether a residual stroke risk of Lp(a) would remain when the LDL-C (low-density lipoprotein cholesterol) and inflammatory…
read more here.
Keywords:
lipoprotein;
recurrence;
versus;
low ldl ... See more keywords